VPS39-LYSMD2 Fusion FISH Probe
The VPS39-LYSMD2 Fusion FISH Probe is used to confirm a fusion of the VPS39 and LYSMD2 genes. The fusion of the VPS39 and LYSMD2 genes has been associated with Brain Lower Grade Glioma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| VPS39-LYSMD2-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| VPS39-LYSMD2-20-RERE | 20 (40 μL) | 200 μL |
|
|
| VPS39-LYSMD2-20-REOR | 20 (40 μL) | 200 μL |
|
|
| VPS39-LYSMD2-20-REGO | 20 (40 μL) | 200 μL |
|
|
| VPS39-LYSMD2-20-REGR | 20 (40 μL) | 200 μL |
|
|
| VPS39-LYSMD2-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| VPS39-LYSMD2-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| VPS39-LYSMD2-20-OROR | 20 (40 μL) | 200 μL |
|
|
| VPS39-LYSMD2-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| VPS39-LYSMD2-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| VPS39-LYSMD2-20-GORE | 20 (40 μL) | 200 μL |
|
|
| VPS39-LYSMD2-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| VPS39-LYSMD2-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| VPS39-LYSMD2-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| VPS39-LYSMD2-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| VPS39-LYSMD2-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| VPS39-LYSMD2-20-GROR | 20 (40 μL) | 200 μL |
|
|
| VPS39-LYSMD2-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| VPS39-LYSMD2-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| VPS39-LYSMD2-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| VPS39-LYSMD2-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| VPS39-LYSMD2-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| VPS39-LYSMD2-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| VPS39-LYSMD2-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| VPS39-LYSMD2-20-AQAQ | 20 (40 μL) | 200 μL |
|
VPS39 Gene Summary
This gene encodes a protein that may promote clustering and fusion of late endosomes and lysosomes. The protein may also act as an adaptor protein that modulates the transforming growth factor-beta response by coupling the transforming growth factor-beta receptor complex to the Smad pathway. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2014]
Gene Name: VPS39, HOPS Complex Subunit
Chromosome: CHR15: 42450898 -42500502
Locus: 15q15.1
LYSMD2 Gene Summary
The LysM Domain Containing 2 (LYSMD2) gene is located on chr15 :52015260-52043650 at 15q21.2.
Gene Name: LysM Domain Containing 2
Chromosome: CHR15: 52015260 -52043650
Locus: 15q21.2
Gene Diseases
The VPS39 LYSMD2 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Brain Lower Grade Glioma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|